(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(naphthalen-2-yl)butanoic acid, 97%, 250mg

4-Isopropylbenzyl Alcohol>98.0%(GC)25mL

ETHYL 4-(2,6-DIFLUOROPHENYL)-2-HYDROXY-4-OXOBUT-2-ENOATE, 95.0%, 1g

(S)-3-(Hydroxymethyl)piperazine-2,5-dione, 95.0%, 5g

(S)-3-(4-(((Benzyloxy)carbonyl)amino)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 1g

3-Bromo-2-ethoxypyridine>97.0%(GC)(T)5g

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone>98.0%(HPLC)(T)25g

N-cyclopropyl-N-(piperidin-4-yl)methanesulfonamide, 95.0%, 250mg

L-Valine, min 98.5%, USP, for biochemistry, 500 g, plastic packaging.

2,4-Dichloro-6,7-dihydrothieno[3,2-d]pyrimidine, 95.0%, 5g

5-Chloro-2-methoxy-3-nitrobenzoic acid, 98%, 100mg

2-(2-Methyl-benzoimidazol-1-yl)-ethylamine, 95.0%, 1g

6-Chloro-3-nitro-5-(trifluoromethyl)pyridin-2-amine, 97.0%, 1g